Fecal immunochemical test (FIT) for colon cancer screening: Variable performance with ambient temperature

Journal of the American Board of Family Medicine

Volumn 29, Issue 6, 2016, Pages 672-681

  Doubeni, Chyke A ^a   Jensen, Christopher D ^b   Fedewa, Stacey A ^c   Quinn, Virginia P ^d   Zauber, Ann G ^e   Schottinger, Joanne E ^d   Corley, Douglas A ^b   Levin, Theodore R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d KAISER PERMANENTE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

California; Cohort studies; Colorectal neoplasms; Early detection of cancer; Hemoglobins; Mass screening; Patient compliance; Postal service; Retrospective studies; Seasons; Temperature; Transportation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; COLONOSCOPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; ENVIRONMENTAL TEMPERATURE; FECAL IMMUNOCHEMICAL TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PATIENT HISTORY OF COLECTOMY; POPULATION BASED CASE CONTROL STUDY; RETROSPECTIVE STUDY; CALIFORNIA; CHEMISTRY; COLORECTAL TUMOR; DEVICES; EARLY CANCER DIAGNOSIS; FALSE POSITIVE RESULT; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; POSTAL MAIL; PROCEDURES; SEASON; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TEMPERATURE;

HEMOGLOBIN;

AGED; CALIFORNIA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; POSTAL SERVICE; RETROSPECTIVE STUDIES; SEASONS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TEMPERATURE;

EID: 84995569113     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2016.06.160060     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917.
3. von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy 2013; 45:51-9.
4. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
5. Leddin DJ, Enns R, Hilsden R, et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol 2010;24:705-14.
6. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149: 659-69.
7. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
8. National Colorectal Cancer Roundtable. National Colorectal Cancer Roundtable. 2016. Available from: http://nccrt.org/about/.
9. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiologic Reviews 2011;33:101-10.
10. Benson VS, Patnick J, Davies AK, et al. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Canc 2008;122:1357-67.
11. Gupta S, Sussman DA, Doubeni CA, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst 2014;106:dju032.
12. Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: Observational study from the Florence district. Gut 2010;59:1511-5.
13. Cha JM, Lee JI, Joo KR, et al. Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci 2012;57:2178-83.
14. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 2007;109: 612-20.
15. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
16. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 2004;39:846-51.
17. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet 1996; 348:1472-7.
18. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
19. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22.
20. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
21. Dancourt V, Hamza S, Manfredi S, et al. Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening. Eur J Cancer Prev 2016;25:109-14.
22. van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009;125:746-50.
23. Digby J, Fraser CG, Carey FA, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol 2013;66:415-9.
24. McDonald PJ, Digby J, Innes C, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis 2013;15: e151-e159.
25. van Roon AH, Hol L, van Vuuren AJ, et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol 2012;107: 99-107.